ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Genelux Corporation

Genelux Corporation (GNLX)

2.35
-0.20
(-7.84%)
Closed July 12 4:00PM
2.35
0.00
( 0.00% )
Pre Market: 4:00AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
2.35
Bid
2.28
Ask
3.10
Volume
10
0.00 Day's Range 0.00
1.71 52 Week Range 32.86
Market Cap
Previous Close
2.35
Open
-
Last Trade
4
@
2.35
Last Trade Time
04:02:36
Financial Volume
-
VWAP
-
Average Volume (3m)
307,147
Shares Outstanding
26,996,740
Dividend Yield
-
PE Ratio
-2.24
Earnings Per Share (EPS)
-1.05
Revenue
170k
Net Profit
-28.3M

About Genelux Corporation

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vac... Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Genelux Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GNLX. The last closing price for Genelux was $2.35. Over the last year, Genelux shares have traded in a share price range of $ 1.71 to $ 32.86.

Genelux currently has 26,996,740 shares outstanding. The market capitalization of Genelux is $63.44 million. Genelux has a price to earnings ratio (PE ratio) of -2.24.

GNLX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.3718.68686868691.982.5981.984006402.28135098CS
4-0.05-2.083333333332.42.5981.713721802.08930997CS
12-1.84-43.91408114564.195.751.713071472.74261832CS
26-10.6-81.853281853312.9513.971.712112964.2189073CS
52-30.51-92.84844796132.8632.861.7118999911.39000201CS
156-3.65-60.8333333333640.981.7115763613.24737622CS
260-3.65-60.8333333333640.981.7115763613.24737622CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DJTTrump Media and Technology Group Corporation
$ 49.64
(60.70%)
1.9M
PHUNPhunware Inc
$ 8.25
(41.51%)
496.97k
CGBSCrown LNG Holdings Ltd
$ 4.71
(37.32%)
309.45k
CPOPPop Culture Group Company Ltd
$ 1.64
(27.13%)
295.68k
DATSDatChat Inc
$ 1.31
(25.96%)
318.01k
GPAKGamer Pakistan Inc
$ 0.1384
(-25.67%)
458
QLGNQualigen Therapeutics Inc
$ 0.35
(-19.37%)
595.98k
EASTEastside Distilling Inc
$ 1.00
(-16.67%)
14.82k
VEVVicinity Motor Corporation
$ 0.61
(-14.46%)
94.07k
KZIAKazia Therapeutics Ltd
$ 0.77
(-14.04%)
190.89k
MAXNMaxeon Solar Technologies Ltd
$ 0.2246
(-5.43%)
2.55M
DJTTrump Media and Technology Group Corporation
$ 49.64
(60.70%)
1.9M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 15.32
(9.27%)
906.87k
SGDSafe and Green Development Corporation
$ 0.4049
(1.77%)
788.97k
AGRIAgriFORCE Growing Systems Ltd
$ 0.0892
(-10.80%)
784.94k

Your Recent History

Delayed Upgrade Clock